Prepacked chromatography columns facilitate manufacturing with single-use technologies. These columns eliminate the need for equipment capital and qualification, asset traceability, calibration, and routine maintenance. Prepacked chromatography columns also reduce expenses related to column-packing resources and associated consumables.
The global prepacked chromatography columns market is estimated to account for US$ 4,263.5 Mn in terms of value by the end of 2027.
Global Prepacked Chromatography Columns Market: Drivers
Increasing investment in R&D of regenerative medicines is expected to boost demand for prepacked chromatography columns, thereby propelling growth of the global prepacked chromatography columns market over the forecast period, For instance, in March 2020, BioStem Life Sciences, a subsidiary of BioStem Technologies Inc. and a developer of regenerative therapies, announced to add R&D laboratory to its Florida, U.S. facility.
Global Prepacked Chromatography Columns Market: Opportunities
Increasing demand for single use prepacked chromatography columns is expected to offer lucrative growth opportunities for players in the global prepacked chromatography columns market. Currently, several single-use prepacked chromatography columns are available in the market that meet regulatory cGMP requirements and industry standards. These columns offer several key features such as scalability, reproducibility, ease of use, and operator safety.
Global Prepacked Chromatography Columns Market: Restraints
Biopharmaceutical manufacturers often switch to packing their own columns, rather than using pre-packed columns in order to control costs. Moreover companies that do not consider longer downtimes as a major issue are less likely to adopt pre-packed disposable columns. Such scenario can be evident in emerging economies, which is expected to limit growth of the market.
The global prepacked chromatography columns market was valued at US$ 2,227.4 Mn in 2019 and is forecast to reach a value of US$ 4,263.5 Mn by 2027 at a CAGR of 8.5% between 2020 and 2027. Increasing investment in R&D of regenerative medicines is expected to boost demand for prepacked chromatography columns
>1L product type held dominant position in the global prepacked chromatography columns market in 2019, accounting for 50.4% share in terms of value, followed by 100–1000 mL and 1–100 mL, respectively. Increasing demand for single use prepacked chromatography columns is expected to assist the growth of the segment during the forecast period
Pharmaceutical Biotechnology segment held dominant position in the global prepacked chromatography columns market in 2019, accounting for 38.1% share in terms of value, the growth of the segment is attributed to rapidly increasing biopharmaceutical industry in emerging economies such as India during the forecast period.
Emergence of pandemic diseases is expected to boost R&D in antibodies, thereby increasing demand for prepacked chromatography columns. For instance, there were 3,525,116 confirmed cases of COVID-19, including 243,540 deaths, as reported to WHO as of May 5, 2020.
The market is witnessing increasing adoption of ion exchange chromatography technique. Most mAb purification processes include at least one ion exchange chromatography step. The process is relatively inexpensive and can be applied early or late during purification process. Ion exchange chromatography is also used to overcome several purification challenges in contract research organizations, nutraceutical companies, food industry, and in water purification.
Global Prepacked Chromatography Columns Market: Competitive Landscape
Major players operating in the global prepacked chromatography columns market include, Danaher Corporation, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., EMD Millipore (Merck KGaA), GE Healthcare, KNAUER Wissenschaftliche Geräte GmbH, Phenomenex, Inc., Repligen Corporation, and Thermo Fisher Scientific, Inc.
Global Prepacked Chromatography Columns Market: Key Developments
April 2020: Agilent Technologies Inc. became a sponsor of My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific research
May 2019: Repligen Corporation announced to add eight manufacturing suites, which include, two manufacturing suites at its Ravensburg, Germany site and six suites at its Waltham, Massachusetts operations, in order to increase production of prepacked chromatography columns